Release Date: 31/10/18 08:12 Summary: September Quarter Activities Report Price Sensitive: Yes Download Document 1007.97KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%